Vaccines

Paxlovid slashed risk of COVID hospital stay in some patients amid Omicron, study suggests CIDRAP

The antiviral drug Paxlovid was tied to a 96% lower relative risk (RR) of COVID-19 hospitalization among high-risk outpatients who didn't complete a primary vaccination series but didn't benefit those who had received at least two doses amid the SARS-CoV-2 Omicron variant, according to a real-world study published yesterday in Clinical Infectious Diseases.

....

How small vaccine stockpiles can stop outbreaks of infectious disease from becoming big If we can’t get this right for known diseases like Marburg, what hope do we have for unknown pandemic threats? Torie Bosch STAT

...while fast-tracking candidate vaccines represents a positive step forward in the race to stop these outbreaks and to improve global health security, it raises an important question. If vaccine candidates already existed for both of these viruses before the outbreaks began, then why weren’t investigational stockpiles of vaccine ready to go when the first cases were detected?

...